Devyser Diagnostics AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 45.4 million compared to SEK 34.2 million a year ago. Net loss was SEK 13.1 million compared to SEK 16.7 million a year ago. Basic loss per share from continuing operations was SEK 0.8 compared to SEK 1.04 a year ago. Diluted loss per share from continuing operations was SEK 0.8 compared to SEK 1.04 a year ago.

For the full year, the company reported sales was SEK 169.3 million compared to SEK 126.6 million a year ago. Net loss was SEK 53.6 million compared to SEK 46 million a year ago. Basic loss per share from continuing operations was SEK 3.31 compared to SEK 2.89 a year ago. Diluted loss per share from continuing operations was SEK 3.31 compared to SEK 2.89 a year ago.